CBX4 and colorectal cancer: To reveal the prognostic potential of CBX4 in colon cancer, DFS in two colorectal cancer cohorts GSE17536 (n = 145) and GSE14333 (n = 226) was analyzed, comparing the dichotomized cases with high and low expression of CBX4.